These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19706521)

  • 1. The intrinsic dynamics of enzymes plays a dominant role in determining the structural changes induced upon inhibitor binding.
    Bakan A; Bahar I
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14349-54. PubMed ID: 19706521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational generation inhibitor-bound conformers of p38 MAP kinase and comparison with experiments.
    Bakan A; Bahar I
    Pac Symp Biocomput; 2011; ():181-92. PubMed ID: 21121046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ClustENM: ENM-Based Sampling of Essential Conformational Space at Full Atomic Resolution.
    Kurkcuoglu Z; Bahar I; Doruker P
    J Chem Theory Comput; 2016 Sep; 12(9):4549-62. PubMed ID: 27494296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using metadynamics and path collective variables to study ligand binding and induced conformational transitions.
    Bešker N; Gervasio FL
    Methods Mol Biol; 2012; 819():501-13. PubMed ID: 22183554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase.
    Morel C; Ibarz G; Oiry C; Carnazzi E; Bergé G; Gagne D; Galleyrand JC; Martinez J
    J Biol Chem; 2005 Jun; 280(22):21384-93. PubMed ID: 15772081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-novo: an automated workflow for efficient structure-based lead optimization.
    Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
    J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptase.
    Temiz NA; Bahar I
    Proteins; 2002 Oct; 49(1):61-70. PubMed ID: 12211016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT.
    Shen L; Shen J; Luo X; Cheng F; Xu Y; Chen K; Arnold E; Ding J; Jiang H
    Biophys J; 2003 Jun; 84(6):3547-63. PubMed ID: 12770866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein conformational transitions coupled to binding in molecular recognition of unstructured proteins: deciphering the effect of intermolecular interactions on computational structure prediction of the p27Kip1 protein bound to the cyclin A-cyclin-dependent kinase 2 complex.
    Verkhivker GM
    Proteins; 2005 Feb; 58(3):706-16. PubMed ID: 15609350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge-guided docking: accurate prospective prediction of bound configurations of novel ligands using Surflex-Dock.
    Cleves AE; Jain AN
    J Comput Aided Mol Des; 2015 Jun; 29(6):485-509. PubMed ID: 25940276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking.
    May A; Zacharias M
    J Med Chem; 2008 Jun; 51(12):3499-506. PubMed ID: 18517186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and selection of flexible proteins for structure-based drug design: backbone and side chain movements in p38 MAPK.
    Subramanian J; Sharma S; B-Rao C
    ChemMedChem; 2008 Feb; 3(2):336-44. PubMed ID: 18081134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.
    You W; Chang CA
    J Chem Inf Model; 2018 May; 58(5):968-981. PubMed ID: 29620886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
    Perola E; Walters WP; Charifson PS
    Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of inhibitor selectivity in MAP kinases.
    Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
    Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based modelling and percolation analysis of conformational dynamics and activation in the CDK2 and CDK4 proteins: dynamic and energetic polarization of the kinase lobes may determine divergence of the regulatory mechanisms.
    Verkhivker GM
    Mol Biosyst; 2017 Oct; 13(11):2235-2253. PubMed ID: 28926061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors.
    Su HP; Yan Y; Prasad GS; Smith RF; Daniels CL; Abeywickrema PD; Reid JC; Loughran HM; Kornienko M; Sharma S; Grobler JA; Xu B; Sardana V; Allison TJ; Williams PD; Darke PL; Hazuda DJ; Munshi S
    J Virol; 2010 Aug; 84(15):7625-33. PubMed ID: 20484498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MM-GB/SA rescoring of docking poses in structure-based lead optimization.
    Guimarães CR; Cardozo M
    J Chem Inf Model; 2008 May; 48(5):958-70. PubMed ID: 18422307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.